• Home
  • BrightGene Bio-Medical Technology Co.,Ltd.
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 5G98
Book a meeting
26
Apr
2027
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
26 Apr 2027 - 28 Apr 2027
stand H2.C62
Book a meeting
16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 62A65
Book a meeting

BrightGene Bio-Medical Technology Co.,Ltd.

About BrightGene Bio-Medical Technology Co.,Ltd.

BrightGene Bio-medical Technology Co Ltd is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. 

We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.

In parallel, we have also developed a special generic pipeline of extremely challenging ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 5G98
  • CPHI Middle East 2027

    CPHI Middle East 2027

    Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
    26 Apr 2027 - 28 Apr 2027
    stand H2.C62
  • CPHI & PMEC China 2027

    CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 62A65
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contact info
Show contact info Hide contact info

Products from BrightGene Bio-Medical Technology Co.,Ltd. (50)

  • MMAF

    Product MMAF

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • MMAE

    Product MMAE

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • Maytansinol

    Product Maytansinol

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-4

    Product DM-4

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-1

    Product DM-1

    • Status: Validated • Usage:  Antibody-drug Conjugate
  • SGB

    Product SGB

    • Status: Commercial • Usage:  For Saxagliptin
  • SGA

    Product SGA

    • Status: Commercial • Usage:  For Saxagliptin
  • Ascomycin

    Product Ascomycin

    • Status: DMF No.: 029433 • Usage: Oncology
  • Pneumocandin B0

    Product Pneumocandin B0

    • Status: DMF Ready • Usage: For Caspofungin
  • Echinocandin B0

    Product Echinocandin B0

    • Status: DMF Ready • Usage: For Anidulafungin
  • POB

    Product POB

    • Status: DMF Ready • Usage: For Posaconazole
  • POA

    Product POA

    • Status: DMF Ready • Usage: For Posaconazole
show all 50 products